Iron chelation in the treatment of neurodegenerative diseases.

Dusek P, Schneider SA, Aaseth J. J Trace Elem Med Biol. 2016 Mar 24. pii: S0946-672X(16)30047-5. doi: 10.1016/j.jtemb.2016.03.010.

Several studies examining effect of chelation therapy in Friedreich’s ataxia have been conducted. Higher doses of deferiprone seem to worsen neurologic symptoms in FRDA; lower doses might be beneficial in younger patients with less severe disease. However, more evidence is needed.

 Iron chelation in the treatment of neurodegenerative diseases.